semaglutide and a1c Ozempic® Pen vs Other Type 2 Diabetes Treatments Frequently Asked Questions | RYBELSUS®
Description
Patients are encouraged to report any suspected adverse reactions to Ozempic via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)
Another potential limitation is that the trials had a one-sequence crossover design, and differences in observation/exposure periods make it difficult to compare safety and tolerability profiles between treatment arms
Nanomed 6 , 815835 (2011)
[DOI] [PubMed] [Google Scholar] 131
Regular follow-up appointments are importanttypically every 3 months if therapy is being adjusted or treatment goals aren't met, and up to every 6 months for stable patients
